TekCapital, Totally PLC, Asos, Escher Group Holdings
What’s cooking in the IPO kitchen?
Eco (Atlantic) Oil & Gas
TSX-V listed oil and gas exploration has announced its intention to float on AIM. Assets in Guyana and Namibia. Proposed £2m-£3m fundraise.
Diversified Gas & Oil
According to LSE website first day of trading on AIM now expected for 30 January.
(TLY.L) 55p £11.01m
The provider of a range of out-of-hospital services to the healthcare sector in the UK, announced that Premier Physical Healthcare Limited (PPH), one of the largest independent providers of physiotherapy services in the South East of the UK and a wholly owned subsidiary of Totally plc, has won a three-year activity-based contract extension with NHS Swale Clinical Commissioning Group (CCG). Under the agreement, PPH will deliver physiotherapy services to the CCG as part of the NHS’s “Any Qualified Provider” framework. FY17E revs of £10.65m and close to break even vs FY16E revs of £3.24m and £1.86m loss.
(RBN.L) 140.5p £23.03m
FY Dec16 trading statement from the custom manufacturer of plastic and paperboard packaging. Revenues are anticipated to be £27.5m for the year, a 5.6% decrease on last year. The primary reasons for this are the previously reported lost business and lower demand for certain categories of branded goods. New business that had been planned for the second half of 2016 has been delayed but will benefit 2017. The movement in average exchange rates has added £0.8m to revenues in 2016. The directors anticipate trading profits for 2016 will be slightly below market expectations (FY16E PBT £2.3mE). In 2017 with significant new business already confirmed plus the full year impact of recently commenced new business from 2016, the directors expect to deliver revenue and earnings growth.
(AD4.L) 7.75p £17.6m
FY Sep 16 results from the provider of IT as a Service. Revenues from continuing operations of £4.9m, including only part-year contributions from companies acquired during the year, of which 66% are recurring. Trading Group EBITDA of £0.9m from continuing operations. Loss for the period of £0.6m (2015: £1.3m). Total of £9.8m new capital raised during the year for acquisitions, working capital and future growth . “Over the last 12 months we have fundamentally changed the shape of the business through a series of acquisitions, disposals and fundraisings. We exit the year with the turnaround activity complete and a solid platform to continue to build on.”
(TEK.L) 36p £12.75m
The international provider of technology and intellectual property services, announced that it has received a “Notice of Allowance” from the US Patent and Trademark Office for its licensed patent application for vibrational energy harvesting from human motion confirming its patent application has been successful. The Directors believe that this new electro-mechanical energy harvest technology has the potential to enable the development of new power generation devices that may be incorporated into footwear to generate power for recharging mobile devices.
(AUK.L) 3.5p £5.78m
FY Sep16 results from international group of architects and interior designers. Achieved revenue target of £20.8m (2015: £18.7m). Profit before tax below target at £0.9m (2015: £1.9m). EPS 0.47p (2015: 1.00p). Cash maintained at £1.8m (2015: £1.9m) with net funds £0.8m after new acquisition loan. Successfully completed acquisition of a major second business in the Middle East to further diversify revenue streams & increase resource capability. Whilst the Group is still confident of its long term position, given the slow down in the UK and the funding requirements in the UAE, the Board has resolved to defer the decision regarding a dividend until the AGM which in March 2017.
Escher Group Holdings
The provider of outsourced, point of service software for use in the postal, retail and financial industries, published a trading update for FY Dec16. Group adjusted EBITDA is expected to be in line with market expectations. Strong cash generation throughout 2016 resulted in Escher achieving a small net positive cash position at year end (net debt at 31 December 2015: $2.7m). Progress continued in developing subscription and maintenance revenues. Recurring revenue streams represented approximately 50% of turnover in 2016. Licensing revenues will continue to be uneven and difficult to forecast, as most postal customers require one-off licensing agreements. FY16E rev £18.8m, EPS 7.6p.
(ASC.L) 5389p £4.5bn
4 month trading statement to December. Retail sales grew strongly, +36% on a reported basis and +30% on a constant currency basis as investments in pricing and proposition continued to gain traction. Medium term reported sales growth guidance remains unchanged at c.20-25% p.a. Following reinvestment of FX and US duty benefits largely into price, guidance for FY17 reported sales growth is increased to c.25-30%. “Including enhanced reinvestment, we remain confident of delivering current market consensus PBT expectations for the year. Capital expenditure is now expected to be in the £150-170m range for the current financial year”. FY Aug 17 rev of £1.8bn, PBT £80.9m.
(STM.L) 38p £22.58m
Pre-close trading update from the cross border financial services provider. The Group has traded in line with market expectations of profit before tax of £2.7 million for 2016. As was anticipated, the pricing initiative taken by the Board in the earlier part of the year has significantly increased the take-on of new business for its QROPS international pensions product with new policies for the second half of the year up by circa 50 per cent on the first half of the year and 27 per cent on the second half of 2015. Impacted H1 profitability, but does result in an increased level of recurring revenue for future years. This leaves STM well placed to deliver significant growth in revenue and profit in 2017.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.